These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28746934)

  • 1. Protective Effects of Salvianolate on Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention: A Prospective Multicenter Randomized Controlled Trial.
    Huang J; Yuan M; Ma J; Liu R; Dong Z; Zhao G; Hang J; Wei J; Ma S; Wei M; Jiang J; Song H; Liu Z; Zhang W; Li J; Lu Z
    Cardiology; 2017; 138(3):169-178. PubMed ID: 28746934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis on efficacy of salvianolate in prevention of contrast-induced nephropathy].
    Xi YT; Yuan LY; Xu ST; Liu XY; Wu W
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2616-2626. PubMed ID: 31359732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
    Jurado-Román A; Hernández-Hernández F; García-Tejada J; Granda-Nistal C; Molina J; Velázquez M; Albarrán A; Tascón J
    Am J Cardiol; 2015 May; 115(9):1174-8. PubMed ID: 25759106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
    Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial.
    Ou Y; Sun SJ; Shi HM; Luo JF; Luo XP; Shen YZ; Chen YF; Fan WH; Liu HY; Shen W
    Chin J Integr Med; 2020 Sep; 26(9):656-662. PubMed ID: 32572777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH; Liu Y; Zhou YL; He PC; Yu DQ; Li LW; Xie NJ; Guo W; Tan N; Chen JY
    Am J Cardiol; 2016 Jun; 117(12):1896-903. PubMed ID: 27161818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
    Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
    Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial.
    Luo Y; Wang X; Ye Z; Lai Y; Yao Y; Li J; Liu X
    Intern Med; 2014; 53(20):2265-72. PubMed ID: 25318787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T; Tanık VO; Aruğaslan E; Karabağ Y; Çağdaş M; Rencüzoğulları İ; Keskin M
    Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Hydration in Contrast-Induced Nephropathy in Patients Who Underwent Primary Percutaneous Coronary Intervention.
    Wang Z; Song Y; A G; Li Y
    Int Heart J; 2019 Sep; 60(5):1077-1082. PubMed ID: 31447466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH; Jiang L; Chen JY; Tan N; Liu Y; He PC
    Int Urol Nephrol; 2016 Oct; 48(10):1675-82. PubMed ID: 27473154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
    Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
    Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
    Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.